ArticleScandinavian journal of primary health care2026
Screening for sarcopenia risk using SARC-F and its relationship with laboratory parameters in primary care.
Article in Scandinavian journal of primary health care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimSarcopenia screening in primary care is limited by time and workload. The aim of this study was to investigate the relationship between SARC-F (Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls)-defined sarcopenia risk and routine laboratory parameters in primary care. Additionally, the study aimed to determine the prevalence of sarcopenia risk, as defined by the SARC-F, in the study population. MATERIALS AND
methodsData were collected from individuals aged 65 and older (
resultsThe study included 396 individuals with an average age of 70 ± 6.3 years, of whom 55.1% were female. Sarcopenia risk was present in 16.9% of participants (20.6% in women and 12.3% in men). Multiple logistic regression analyses showed that increased age (OR = 1.250, 95% CI = 1.177-1.327), female sex (OR = 2.284, 95% CI = 1.057-4.934), higher BMI (body mass index) (OR = 1.106, 95% Cl = 1.026-1.193), lower ferritin (OR = 0.992, 95% Cl = 0.985-1.000), and lower albumin (OR = 0.777, 95% Cl = 0.693-0.871) levels were associated with an increased risk of sarcopenia.
conclusionThe results of our study indicate that the risk of sarcopenia can be quite a common clinical condition in primary care. When increased clinical demands and limited time hinder the use of tests such as SARC-F, routine laboratory tests may help identify individuals at risk of sarcopenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.